AR110799A2 - PROTEINS OF UNION TO ANTIGEN AGAINST PROPROTEIN CONVERTASA SUBTILISINA / KEXINA TYPE 9 (PCSK9) - Google Patents

PROTEINS OF UNION TO ANTIGEN AGAINST PROPROTEIN CONVERTASA SUBTILISINA / KEXINA TYPE 9 (PCSK9)

Info

Publication number
AR110799A2
AR110799A2 ARP180100333A ARP180100333A AR110799A2 AR 110799 A2 AR110799 A2 AR 110799A2 AR P180100333 A ARP180100333 A AR P180100333A AR P180100333 A ARP180100333 A AR P180100333A AR 110799 A2 AR110799 A2 AR 110799A2
Authority
AR
Argentina
Prior art keywords
pcsk9
proteins
kexina
convertasa
subtilisina
Prior art date
Application number
ARP180100333A
Other languages
Spanish (es)
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of AR110799A2 publication Critical patent/AR110799A2/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Se describen proteínas de unión a antígeno que interactúan con la proproteína convertasa subtilisina / kexina tipo 9 (PCSK9). Se describen métodos para tratar la hipercolesterolemia y otros trastornos, que comprenden administrar una cantidad eficaz para el uso farmacéutico de una proteína de unión a antígeno contra PCSK9. Se describen métodos para detectar la cantidad de PCSK9 en una muestra usando una proteína de unión a antígeno contra PCSK9.Antigen binding proteins that interact with proprotein convertase subtilisin / kexin type 9 (PCSK9) are described. Methods for treating hypercholesterolemia and other disorders are described, which comprise administering an amount effective for the pharmaceutical use of an antigen-binding protein against PCSK9. Methods for detecting the amount of PCSK9 in a sample using an antigen-binding protein against PCSK9 are described.

ARP180100333A 2007-08-23 2018-02-09 PROTEINS OF UNION TO ANTIGEN AGAINST PROPROTEIN CONVERTASA SUBTILISINA / KEXINA TYPE 9 (PCSK9) AR110799A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95766807P 2007-08-23 2007-08-23

Publications (1)

Publication Number Publication Date
AR110799A2 true AR110799A2 (en) 2019-05-02

Family

ID=53675364

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP180100333A AR110799A2 (en) 2007-08-23 2018-02-09 PROTEINS OF UNION TO ANTIGEN AGAINST PROPROTEIN CONVERTASA SUBTILISINA / KEXINA TYPE 9 (PCSK9)

Country Status (2)

Country Link
AR (1) AR110799A2 (en)
UA (1) UA108734C2 (en)

Also Published As

Publication number Publication date
UA108734C2 (en) 2015-06-10

Similar Documents

Publication Publication Date Title
AR068011A1 (en) PROTEINS OF ANTIGEN UNION AGAINST PROPROTEIN CONVERTASA SUBTILISINA / KEXINA TYPE 9 (PCSK9)
EA201200861A1 (en) PCTA9 ANTAGONISTS
EA200901376A1 (en) MOLECULES AND METHODS OF MODULATION PROPROTEINKONVERTASY SUBTILYZIN / KEKINOVYY TYPE 9 (PCSK9)
AU2014274844A8 (en) Methods for inhibiting atherosclerosis by administering an inhibitor of PCSK9
AR077724A1 (en) HIGH AFFINITY HUMAN ANTIBODIES AGAINST PCSK9
CY1126125T1 (en) SUBTILYSIN KEXIN TYPE 9 (PCSK9) ANTIGEN BINDING PROTEIN CONVERTING PROTEIN
EA201391157A1 (en) PCTA9 ANTAGONISTS
PE20140372A1 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING HUMAN ANTIBODIES VS. PCSK9
EA201690889A1 (en) DOSING MODES FOR USING PCSK9 INHIBITORS
PE20140190A1 (en) NOTUM PROTEIN MODULATORS AND METHODS OF USE
AR110799A2 (en) PROTEINS OF UNION TO ANTIGEN AGAINST PROPROTEIN CONVERTASA SUBTILISINA / KEXINA TYPE 9 (PCSK9)
EP2641918A3 (en) Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
EA201892670A1 (en) ANTIGEN-BINDING PROTEINS BINDING PROPROTEIN CONVERTASE SUBTILYSINE KEXIN TYPE 9 (PCSK9)
CL2008001032A1 (en) Antigen-binding molecule of antibodies against an epitope of the pro-protein convertase-subtilisin / quexin polypeptide (pcsk9), a composition comprising it and use to prepare a medicament for hypercholesterolemia.